Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy

The objective of the present study was to evaluate the duodenal mucosa of HIV-infected patients during antiretroviral therapy. This was an observational study conducted on HIV-positive patients and a control group. Group 1 comprised 22 HIV-negative individuals while 38 HIV-positive individuals were...

Full description

Bibliographic Details
Main Authors: F.R. Machado, C. Pagliari, H. Caiafa, R. Tapajós, M.I.S. Duarte
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2006-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100013
_version_ 1828791883768266752
author F.R. Machado
C. Pagliari
H. Caiafa
R. Tapajós
M.I.S. Duarte
author_facet F.R. Machado
C. Pagliari
H. Caiafa
R. Tapajós
M.I.S. Duarte
author_sort F.R. Machado
collection DOAJ
description The objective of the present study was to evaluate the duodenal mucosa of HIV-infected patients during antiretroviral therapy. This was an observational study conducted on HIV-positive patients and a control group. Group 1 comprised 22 HIV-negative individuals while 38 HIV-positive individuals were classified according to the CDC 1993 classification into group 2 (A1 or A2) or group 3 (B2, A3, B3, C2, C3). All subjects were submitted to upper gastrointestinal endoscopy with duodenal biopsies. Qualitative, semi-quantitative and quantitative histological analyses were performed. Results were considered significant when P < 0.05. A higher prevalence of inflammatory infiltrate and eosinophilia was observed in the HIV group, together with a reduction in mucosal CD4+ lymphocyte (L) counts [median (lower-upper quartiles), 12.82 (8.30-20.33), 6.36 (1.75-11.66) and 1.75 (0.87-3.14) in groups 1, 2 and 3, respectively] which was not correlated with disease stage. The extent of CD4+L count reduction was similar in blood and duodenal mucosa. Normal CD8+L and CD45RO+L counts, and normal numbers of macrophages and antigen-presenting cells were also found in the HIV patients. The cytokine pattern did not differ among groups. Tissue HIV, assessed by p24 antigen, correlated with a higher CD45RO+L count (77.0 (61-79.8) and 43.6 (31.7-62.8) in p24+ and p24-, respectively, P = 0.003), and IL-4 positivity (100 and 48.2% in p24+ and p24-, respectively, P = 0.005). The duodenal mucosa of HIV+ patients showed a relatively preserved histological architecture. This finding may be characteristic of a population without opportunistic infections and treated with potent antiretroviral therapy, with a better preservation of the immune status.
first_indexed 2024-12-12T02:58:34Z
format Article
id doaj.art-12c8fdfadac743deb14cd5559f2b0a65
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-12T02:58:34Z
publishDate 2006-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-12c8fdfadac743deb14cd5559f2b0a652022-12-22T00:40:41ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2006-01-0139110711710.1590/S0100-879X2006000100013Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapyF.R. MachadoC. PagliariH. CaiafaR. TapajósM.I.S. DuarteThe objective of the present study was to evaluate the duodenal mucosa of HIV-infected patients during antiretroviral therapy. This was an observational study conducted on HIV-positive patients and a control group. Group 1 comprised 22 HIV-negative individuals while 38 HIV-positive individuals were classified according to the CDC 1993 classification into group 2 (A1 or A2) or group 3 (B2, A3, B3, C2, C3). All subjects were submitted to upper gastrointestinal endoscopy with duodenal biopsies. Qualitative, semi-quantitative and quantitative histological analyses were performed. Results were considered significant when P < 0.05. A higher prevalence of inflammatory infiltrate and eosinophilia was observed in the HIV group, together with a reduction in mucosal CD4+ lymphocyte (L) counts [median (lower-upper quartiles), 12.82 (8.30-20.33), 6.36 (1.75-11.66) and 1.75 (0.87-3.14) in groups 1, 2 and 3, respectively] which was not correlated with disease stage. The extent of CD4+L count reduction was similar in blood and duodenal mucosa. Normal CD8+L and CD45RO+L counts, and normal numbers of macrophages and antigen-presenting cells were also found in the HIV patients. The cytokine pattern did not differ among groups. Tissue HIV, assessed by p24 antigen, correlated with a higher CD45RO+L count (77.0 (61-79.8) and 43.6 (31.7-62.8) in p24+ and p24-, respectively, P = 0.003), and IL-4 positivity (100 and 48.2% in p24+ and p24-, respectively, P = 0.005). The duodenal mucosa of HIV+ patients showed a relatively preserved histological architecture. This finding may be characteristic of a population without opportunistic infections and treated with potent antiretroviral therapy, with a better preservation of the immune status.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100013Intestinal histopathologyCytokinesHuman immunodeficiency virusAcquired immunodeficiency syndromeAntiretroviral therapyCD4+
spellingShingle F.R. Machado
C. Pagliari
H. Caiafa
R. Tapajós
M.I.S. Duarte
Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
Brazilian Journal of Medical and Biological Research
Intestinal histopathology
Cytokines
Human immunodeficiency virus
Acquired immunodeficiency syndrome
Antiretroviral therapy
CD4+
title Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_full Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_fullStr Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_full_unstemmed Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_short Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_sort immunopathology of the duodenal mucosa of hiv positive patients during combined antiretroviral therapy
topic Intestinal histopathology
Cytokines
Human immunodeficiency virus
Acquired immunodeficiency syndrome
Antiretroviral therapy
CD4+
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100013
work_keys_str_mv AT frmachado immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT cpagliari immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT hcaiafa immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT rtapajos immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT misduarte immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy